| Autor: |
Thornewill, Judah, Antimisiaris, Demetra, Ezekekwu, Emmanuel, Esterhay, Robert |
| Zdroj: |
Journal of the American Pharmacists Association: JAPhA; 20210101, Issue: Preprints |
| Abstrakt: |
Nonoptimized medication therapies (NOMTs) are associated with likely avoidable illnesses and mortality affecting millions of people and costing an estimated $528 billion per year in excess health spending in the United States. The coronavirus disease 2019 (COVID-19) pandemic brought into focus barriers limiting the ability of U.S. pharmacists and pharmacies to provide services that can reduce NOMTs and improve U.S. population health. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
